Trial Profile
Post-marketing surveillance of donepezil hydrochloride -Investigation of the safety and effectiveness of combination therapy of donepezil hydrochloride and memantine hydrochloride in patients with Alzheimer's Disease (Study ART07T)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2018
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 07 Apr 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClnicalTrials.gov.
- 19 Jun 2014 New trial record